Brief: Bliss Gvs Pharma Got Establishment Inspection Report For Palghar Unit From US FDA

Bliss GVS Pharma

15/06/2023 09:40

June 15 (Reuters) - Bliss GVS Pharma Ltd  BLIS.NS :
    * GOT ESTABLISHMENT INSPECTION REPORT FOR PALGHAR UNIT FROM
US FDA
    * US FDA AGENCY ASSIGNED INSPECTION CLASSIFICATION OF
FACILITY AS
VOLUNTARY ACTION INDICATED

Source text for Eikon:  ID:nBSE24NSlj 
Further company coverage:  BLIS.NS 

 ((Reuters.Briefs@thomsonreuters.com;;))